Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Bevacizumab
Child
Child, Preschool
Gestational Age
Humans
Intravitreal Injections
Laser Coagulation
Retinopathy of Prematurity
Retrospective Studies
authors with profiles
Michael P Blair
Sarah Rodriguez